Announcement Biolexis Therapeutics, an evolving champion in presenting best-in-class inflammation-targeted and next-generation metabolic therapies, proudly announced its selection for the two presentations at the 2nd Innovation in Obesity Therapeutics Summit. To present the company’s clinica...
Announcement After Novo Nordisk reduced the price of its renowned GLP-1 medicines, Eli Lilly is set to put a discount tag on its obesity drug (Zepbound), available via LillyDirect. Here, both pharma companies are trying to reach patients with affordable drugs, but they are stuck in negotiations wi...
Uncountable clinical and financial efforts Where many of the giant pharma, including Novo Nordisk and Takeda, left the cell therapy ground and small biotechs closed their operations, a few players are giving their endless efforts to stretch the modality as long as they can. In the last few months, ...
Announcement Where Freya Pharma Solutions itself has been a promising pharmaceutical company expert in innovative therapies for women suffering from Female Sexual Disorders (FSD), its rebrand announcement is the same, promising, with a level-up. The Freya Phar, a solutions has been renamed to Arle...
Announcement Konica Minolta Healthcare Americas, Inc., a known healthcare IT solutions and medical diagnostic imaging provider, proudly introduced its new KDR FMT and KDR FMT+ digital radiography (DR) systems at the Annual Meeting of the Radiological Society of North America (RSNA) 2025. These new...
Announcement FUJIFILM Healthcare Americas Corporation, a pioneering champion in enterprise and diagnostic imaging solutions, will be ramping up its current diagnostic imaging innovations in the South Hall at the 2025 Radiological Society of North America (RSNA) annual meeting (booth #3300), McCorm...
Announcement Pasithea Therapeutics Corp., a leading clinical-level biotechnology company establishing a next-generation macrocyclic MEK inhibitor, PAS-004, is delighted to announce that its PAS-004 study in ALS patients has been awarded a Hoffman ALS Clinical Trial Award from the ALS Association w...
Announcement Eli Lilly and Company expressed its double excitement by confirming that it will be showcasing the new data from throughout its breast oncology portfolio and the robust pipeline at the San Antonio Breast Cancer Symposium (SABCS) in San Antonio, Texas, December 9-12. These new updates ...
Announcement From July, several biotechs were forced to spin off as existing partnerships with the FDA around proofs needed for approval signalled a reversal. As per the experts, this will put the examination and approval process in a stage of more restrictive regulatory possibility. As learned in...
Announcement The sceptical and the headlines creating a debate environment are spotting the cell and gene therapy area of late. The renewal of the efforts and that required motivation is not just warranted but very important if these therapies are close to achieving their full potential value. The...
